Injectable biphasic calcium phosphate bioceramic: The HYDROS concept.

This study aimed to evaluate a newly developed biphasic calcium phosphate ceramic material composed of hydroxyapatite and beta-tricalcium phosphate. The material was designed to be injectable and suitable for bone repair applications. Researchers wanted to assess both biocompatibility and osteogenic potential in a controlled animal model. The specific problem addressed was whether a material with three distinct particle sizes could enhance bone regeneration. The motivation stemmed from the need for a versatile, injectable bone graft substitute. The study sought to determine how each particle size contributes to the material's performance. Researchers focused on whether the submicron particles would be resorbed while larger particles provided structural support. The goal was to create a bioceramic that could adapt to complex defect shapes while promoting bone ingrowth.

The researchers developed a biphasic calcium phosphate ceramic with a 60% hydroxyapatite and 40% beta-tricalcium phosphate composition. The material was created using three distinct particle sizes: submicron, round microporous (80-200 µm), and macro microporous (0.5-1 mm). The ceramic was hydrated with water to form a putty-like consistency suitable for injection. The biocompatibility and osteogenicity of the material were tested in a rabbit model. Critical size bone defects were created in femoral epiphyses and lumbar muscles for implantation. After 3, 6, and 12 weeks, the implanted materials were retrieved for histological analysis. The study focused on tracking resorption patterns and bone ingrowth across the different particle sizes. Histological techniques were used to assess the integration of the material with surrounding tissue.

Histological analysis revealed that the material was biocompatible with no adverse reactions observed. The submicron particle fraction was extensively resorbed within the 12-week period. Bone ingrowth was significant, particularly in regions containing submicron particles. The larger particles provided a scaffold for osteoconduction, allowing new bone to grow into the material. The microporous structure of the larger particles supported cell infiltration and tissue integration. The combination of particle sizes created a gradient of resorption and bone formation. No signs of inflammation or rejection were observed in the implanted areas. The results suggest that the biphasic composition effectively promotes bone regeneration while being safely resorbed.

The authors concluded that the biphasic calcium phosphate ceramic is biocompatible and suitable for bone repair applications. The submicron particles were resorbed at a faster rate compared to larger particles. The larger particles provided structural support and facilitated osteoconduction. The material’s putty-like consistency allowed for easy injection into bone defects. The study demonstrated that the combination of particle sizes enhances both resorption and bone ingrowth. The findings suggest that this material could be a viable alternative to existing bone graft substitutes. The researchers propose that the biphasic composition optimizes the balance between resorption and structural integrity. These results support further investigation into the clinical application of this bioceramic material.